sociated with far greater adverse consequences relative to mild obesity (with a body mass index [BMI] of 30.0-34.9 [calculated as weight in kilograms divided by height in meters squared]). Lesser access to treatment for the severely obese in socioeconomically disadvantaged populations would risk further widening inequalities. Bariatric surgery is currently the only evidence-based option available that induces significant and sustained weight loss in severely obese patients. 3 The present study aims to quantify the rates of treatment of severe obesity using bariatric surgery, according to the socioeconomic positions of severely obese Australian adults.
Methods | Customized data relating to all bariatric surgery episodes undertaken in Australian adults between July 2011 and June 2012 (n = 14 056) were obtained from the National Hospital Morbidity database and provided by the Australian Institute of Health and Welfare. 4 Bariatric surgery episodes were selected based on 3 Australian Refined Diagnosis Related Groups codes (K04A-S, K04B-S, and K07Z-S Bariatric surgery rates were calculated as the observed annual number of bariatric surgery episodes divided by the estimated annual number of adults with severe obesity for each socioeconomic stratum in Australia (2011-2012). Severe obesity was defined as either class II (BMI = 35.0-39.9) or class III obesity (BMI ≥ 40.0) and represented the population potentially eligible to receive bariatric surgery. Equitable treatment across socioeconomic strata would be represented by roughly equal treatment rates.
The statistical significance of these comparisons was assessed using a z score and an associated P value. The z score was calculated as the difference between the annual treatment rate estimates divided by the standard error of this difference, with this standard error calculated as the square root of the sum of the squares of the individual annual treatment rate standard errors ( Figure) . Associated P values were derived using the standard normal probability distribution: quintile 5 vs quintile 4 (P = .25), quintile 5 vs quintile 3 (P = .17), quintile 5 vs quintile 2 (P < .001), and quintile 5 vs quintile 1 (P < .001). Results | The lowest annual treatment rates were observed in the most disadvantaged quintiles (quintiles 1/2: 7.9/8.1 episodes per 1000 severely obese adults), whereas the highest treatment rates were observed in the least disadvantaged quintiles (quintiles 4/5: 13.6/12.6 episodes per 1000 severely obese adults) (Figure) . During 2011-2012, severely obese people in the 2 most disadvantaged quintiles were approximately 40% less likely to receive bariatric surgery relative to counterparts in the 2 least disadvantaged quintiles.
Discussion | The present study found socioeconomic differences in the treatment of severe obesity using bariatric surgery among Australian adults. These findings are supported by a previous study in the United States. 6 It is likely that these treatment inequalities will further increase the already large number of socioeconomic inequalities in the prevalence and consequences of severe obesity. A limitation of the present analysis is that the severely obese population potentially eligible for surgery will include a small number of people with class II obesity and no associated morbidity who are currently ineligible. This analysis relates to Australia, where bariatric surgery is primarily available through the private hospital system (89% of episodes in 2011-2012) 4 ; eligible patients must have private health insurance and pay an out-of-pocket fee. In the public hospital setting (11% of 2011-2012 episodes), no fees are incurred by patients; however, long wait times are common. Affordability is likely to be a key contributor to the observed socioeconomic inequalities. Other factors, such as geographical access to services and health literacy, may also play a role. Access to bariatric surgery for disadvantaged groups should be improved so that all members in society can benefit from this treatment. In Australia, this will most likely be achieved by increasing the funding allocated to bariatric surgery in public hospitals. Future research should examine the costs and benefits of bariatric surgery according to socioeconomic strata.
Population-Based Estimates of the Prevalence of Uterine Sarcoma Among Patients With Leiomyomata Undergoing Surgical Treatment
Uterine leiomyomata are one of the most common gynecologic problems among women in the United States, with an annual diagnosis range from 2.0 to 12.8 per 1000 reproductiveage women.
1 Intervention is a standard management for symptomatic patients, and various procedures include open and laparoscopic hysterectomy, myolysis, uterine artery embolization, and magnetic resonance-guided focused ultrasonographic surgery. The practice of electric morcellation has been used by gynecologic surgeons during laparoscopic and robotic-assisted hysterectomies and myomectomies as a less invasive alternative to open surgery. 2 In April 2014, the US Food and Drug Administration (FDA) stated that they discouraged the use of this technique over concern that morcellation may spread unsuspected sarcoma tissue. 3, 4 Based on the literature, the FDA reported that 1 in 352 women have unsuspected uterine sarcoma while undergoing surgery for presumed benign leiomyoma. 5 A recent study 6 using an all-payer database found that 1 in 368 women who underwent morcellation had uterine cancer. However, the estimates in this study 6 were lim-
